The Lancet, a top-ranking medical journal, has published results from pharmaceutical firm Lundbeck’s Deliver study of migraine drug Vyepeti, the firm announced in a press release on Thursday.
“We are incredibly proud that our clinical research is recognized by the medical and scientific community. The publication of the Deliver results by Lancet Neurology is a clear indication that Lundbeck performs clinical research of the highest quality, and that the results of these efforts are relevant to both clinicians and patients,” says Lundbeck Head of R&D Johan Luthman in the statement.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Bavarian Nordic to supply US with additional 2.5 million monkeypox vaccines
The deliveries will start in the fourth quarter of 2022 and continue into 2023, when the majority of the doses will be provided.
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and partner Abbvie in the second half of this year.
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
The Danish Medicines Agency has been told for the second time that the price of the obesity drug is not in line with the effect it provides.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Coloplast's climate goals approved by international initiative
The Science Based Targets initiative has approved Coloplast’s carbon emission reduction goals.
Project Mgr for Medical Device Development 
Corporate Quality Compliance Specialists 
Medical Advisor 
KLIFO is looking for a Project Director for our office in Denmark or Germany or Sweden 
Senior Scientist for Analytical Development 
Chair of the Board 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Nordic Medical Advisor 
Global Product Manager - Pulmonology 
Senior Teaching Fellow for the BioMedical Design Novo Nordisk Foundation Fellowship Program 
Senior DMPK Laboratory Technologist 
Regulatory Affairs Manager - Maternity Cover 
Project Managers keep all of us healthy